Kurt H Kruger insider trades: Qualigen Therapeutics (QLGN) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kurt reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 19, 2021 | QLGN | ↑ Buy | 8,000 | $1.23 | $10K | Direct | Aug 20, 2021 (1d) |
| Dec 29, 2020 | QLGN | ↑ Buy | 4,000 | $2.94 | $12K | Direct | Dec 30, 2020 (1d) |
| Nov 23, 2020 | QLGN | ↑ Buy | 6,000 | $3.48 | $21K | Direct | Nov 23, 2020 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kurt H Kruger's insider trades
Kurt H Kruger is a director at Qualigen Therapeutics (QLGN). Since Nov 23, 2020, Kurt has reported 3 open-market purchases worth $42K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every QLGN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.